These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 19761982)
21. A comparison of the hemolytic potential of Optison and Albunex in whole human blood in vitro: acoustic pressure, ultrasound frequency, donor and passive cavitation detection considerations. Miller MW; Everbach EC; Cox C; Knapp RR; Brayman AA; Sherman TA Ultrasound Med Biol; 2001 May; 27(5):709-21. PubMed ID: 11397535 [TBL] [Abstract][Full Text] [Related]
22. Acoustic radiation force impulse under clinical conditions with single infusion of ultrasound contrast agent evoking arrhythmias in rabbit heart. Rifu K; Sasanuma H; Takayama N; Nitta N; Ogata Y; Akiyama I; Taniguchi N J Med Ultrason (2001); 2021 Apr; 48(2):137-144. PubMed ID: 33837866 [TBL] [Abstract][Full Text] [Related]
23. The threshold for brain damage in rabbits induced by bursts of ultrasound in the presence of an ultrasound contrast agent (Optison). Hynynen K; McDannold N; Martin H; Jolesz FA; Vykhodtseva N Ultrasound Med Biol; 2003 Mar; 29(3):473-81. PubMed ID: 12706199 [TBL] [Abstract][Full Text] [Related]
24. The safety profile of perflutren microsphere contrast echocardiography during rest and stress imaging: results from an Australian multicentre cohort. Platts DG; Luis SA; Roper D; Burstow D; Call T; Forshaw A; Pascoe R Heart Lung Circ; 2013 Dec; 22(12):996-1002. PubMed ID: 23764145 [TBL] [Abstract][Full Text] [Related]
25. Impact of myocardial contrast echocardiography on vascular permeability: comparison of three different contrast agents. Li P; Armstrong WF; Miller DL Ultrasound Med Biol; 2004 Jan; 30(1):83-91. PubMed ID: 14962612 [TBL] [Abstract][Full Text] [Related]
26. Assessment of myocardial perfusion during pharmacologic contrast stress echocardiography. Oraby MA; Hays J; Maklady FA; El-Hawary AA; Zabalgoitia M Am J Cardiol; 2002 Mar; 89(5):640-4. PubMed ID: 11867062 [No Abstract] [Full Text] [Related]
27. The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. Wei K; Mulvagh SL; Carson L; Davidoff R; Gabriel R; Grimm RA; Wilson S; Fane L; Herzog CA; Zoghbi WA; Taylor R; Farrar M; Chaudhry FA; Porter TR; Irani W; Lang RM J Am Soc Echocardiogr; 2008 Nov; 21(11):1202-6. PubMed ID: 18848430 [TBL] [Abstract][Full Text] [Related]
28. Clinical benefits of using second generation ultrasound contrast agents in stress echocardiography. Jung PH; Angermann CE Echocardiography; 2003 Aug; 20 Suppl 1():S11-8. PubMed ID: 23573621 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic ultrasound-induced membrane damage in phagocytic cells loaded with contrast agent and its relation to Doppler-mode images. Miller DL; Quddus J IEEE Trans Ultrason Ferroelectr Freq Control; 2002 Aug; 49(8):1094-102. PubMed ID: 12201456 [TBL] [Abstract][Full Text] [Related]
30. Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing. Thanigaraj S; Nease RF; Schechtman KB; Wade RL; Loslo S; Pérez JE Am J Cardiol; 2001 Jun; 87(12):1430-2. PubMed ID: 11397374 [No Abstract] [Full Text] [Related]
31. Theoretical gas body pulsation in relation to empirical gas-body destabilization and to cell membrane damage thresholds. Miller DL; Dou C J Acoust Soc Am; 2004 Dec; 116(6):3742-9. PubMed ID: 15658724 [TBL] [Abstract][Full Text] [Related]
32. Contrast echocardiography: safety in numbers. Main ML Cardiology; 2012; 122(4):248-50. PubMed ID: 22906912 [No Abstract] [Full Text] [Related]
33. Membrane damage thresholds for 1- to 10-MHz pulsed ultrasound exposure of phagocytic cells loaded with contrast agent gas bodies in vitro. Miller DL; Dou C Ultrasound Med Biol; 2004 Jul; 30(7):973-7. PubMed ID: 15313329 [TBL] [Abstract][Full Text] [Related]
34. [Left ventricular opacification and stress echocardiography]. Brochet E Ann Cardiol Angeiol (Paris); 2002 Sep; 51(4):212-3. PubMed ID: 12471803 [TBL] [Abstract][Full Text] [Related]
35. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent: results in 18,671 consecutive studies. Kusnetzky LL; Khalid A; Khumri TM; Moe TG; Jones PG; Main ML J Am Coll Cardiol; 2008 Apr; 51(17):1704-6. PubMed ID: 18436124 [TBL] [Abstract][Full Text] [Related]
37. Safety of contrast administration for endocardial enhancement during stress echocardiography compared with noncontrast stress. Shaikh K; Chang SM; Peterson L; Rosendahl-Garcia K; Quinones MA; Nagueh SF; Kurrelmeyer K; Zoghbi WA Am J Cardiol; 2008 Dec; 102(11):1444-50. PubMed ID: 19026293 [TBL] [Abstract][Full Text] [Related]
38. Use of contrast echocardiography in the diagnosis of subacute myocardial rupture after myocardial infarction. García-Fernández MA; Macchioli RO; Moreno PM; Yangüela MM; Thomas JB; Sendón JL; Lopez de Sa E; Abdou YH J Am Soc Echocardiogr; 2001 Sep; 14(9):945-7. PubMed ID: 11547284 [TBL] [Abstract][Full Text] [Related]
39. Cardiac arrhythmia and injury induced in rats by burst and pulsed mode ultrasound with a gas body contrast agent. Miller DL; Dou C; Lucchesi BR J Ultrasound Med; 2009 Nov; 28(11):1519-26. PubMed ID: 19854967 [TBL] [Abstract][Full Text] [Related]
40. Stress echocardiography for risk assessment in octogenarians. Cortigiani L; Bigi R; Bovenzi F; Picano E; Sicari R Int J Cardiol; 2013 Sep; 167(5):2356-8. PubMed ID: 23206522 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]